Experimental COVID-19 vaccine safe, generates immune response

NIAID-sponsored Phase 1 trial tested mRNA vaccine Date: July 14, 2020 Source 1: NIH/National Institute of Allergy and Infectious Diseases Source 2: Summary: An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to […]